Sleeping beauty? Definitely undervalued
Appears to be little to no interest from retail investors.
Lacks volume for most traders,
Since its continues to grow the business through acquisition while turning some decent numbers and having a line of credit "untouched to date of 32 million".
Who has patience for the undervalued?
Now will carefully look for an entry point to begin cost average into serious accumilation of TTR.
Since May 15th >>>
Cormach 515k @ 1.15
100k @1.15
Canacord 610 K cross
I like it, so it’s a buy & hold for next 14-18 months.
Cheers